RECRUITING

Telemedicine-Based Virtual Reality Clinic for the Treatment of Phobias

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to assess the feasibility of conducting a randomized controlled efficacy trial comparing the delivery of exposure therapy via a telemedicine-based virtual reality clinic (Doxy.me VR) vs. standard telemental health (TMH) to adults with intense fear of dogs, snakes, and/or spiders. The secondary purpose is to preliminarily examine the efficacy of using Doxy.me VR vs. TMH in reducing phobia severity.

Official Title

Doxy.me VR vs. Telemental Health-Based Exposure Therapy

Quick Facts

Study Start:2023-10-03
Study Completion:2024-08-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06302868

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Is an adult ≥ 18 years old
  2. 2. Has a self-reported fear of dogs, snakes, and/or spiders
  3. 3. Indicates Subthreshold or Present Specific Phobia symptoms as determined by the study therapist via administration of the Diagnostic Assessment Research Tool (DART) Specific Phobia Module
  4. 4. Has access to the internet AND a computer OR smartphone with video conferencing capabilities
  5. 5. Will reside in the state of Florida for the duration of the study
  1. 1. Is participating in ongoing mental health therapy from a non-study therapist
  2. 2. Has had changes to psychotropic medication use within six weeks preceding enrollment in the trial
  3. 3. Reports active suicidal and/or homicidal intent or plan as determined by the study therapist via administration of the Diagnostic Assessment Research Tool (DART) Risk Assessment Module
  4. 4. Reports active auditory, visual, and/or tactile hallucinations via the Diagnostic Assessment Research Tool (DART) Psychosis Module screening question
  5. 5. Reports a history of epilepsy or seizures

Contacts and Locations

Study Contact

Kaitlyn R Schuler, PhD
CONTACT
813-396-9169
krschuler@usf.edu

Principal Investigator

Brian E Bunnell, PhD
PRINCIPAL_INVESTIGATOR
University of South Florida

Study Locations (Sites)

University of South Florida
Tampa, Florida, 33613
United States

Collaborators and Investigators

Sponsor: University of South Florida

  • Brian E Bunnell, PhD, PRINCIPAL_INVESTIGATOR, University of South Florida

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-10-03
Study Completion Date2024-08-01

Study Record Updates

Study Start Date2023-10-03
Study Completion Date2024-08-01

Terms related to this study

Keywords Provided by Researchers

  • phobia
  • phobias
  • snakes
  • dogs
  • spiders

Additional Relevant MeSH Terms

  • Arachnophobia
  • Cynophobia
  • Ophidiophobia